Atossa Therapeutics
ATOS
#10507
Rank
NZ$40.67 M
Marketcap
NZ$4.08
Share price
-2.07%
Change (1 day)
176.61%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): NZ-$6.79

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$6.84. In 2025 the company made an earnings per share (EPS) of NZ-$6.98 a decrease over its 2024 EPS that were of NZ-$5.25.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.79-2.79%
2025NZ-$6.9832.89%
2024NZ-$5.25-15.56%
2023NZ-$6.2214.29%
2022NZ-$5.4416.67%
2021NZ-$4.67-90.86%
2020NZ-$51.06-2.96%
2019NZ-$52.61-63.09%
2018NZ-$142.55-49.63%
2017NZ-$283.03-57.87%
2016NZ-$671.81-74.01%
2015NZ-$2,585-9.18%
2014NZ-$2,846-12.86%
2013NZ-$3,26670.73%
2012NZ-$1,91334.07%
2011NZ-$1,427263.41%
2010NZ-$392.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.09-320.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.84-331.57%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.63-386.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.33-80.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-94.70%๐Ÿ‡บ๐Ÿ‡ธ USA